Antibody Responses Against Emerging SARS-CoV-2 Omicron Lineages After the Fourth Dose of mRNA Vaccine in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Antibody Responses Against Emerging SARS-CoV-2 Omicron Lineages After the Fourth Dose of mRNA Vaccine in Kidney Transplant Recipients

Published:2023-05-23 Issue:6 Volume:107 Page:e178-e181
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Al Jurdi Ayman¹²,Gassen Rodrigo B.¹,Borges Thiago J.¹,Lape Isadora T.¹,Morena Leela¹,Hullekes Frank¹,Efe Orhan¹²,Kotton Camille N.³,Riella Leonardo V.¹²

Affiliation:

1. Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA.

2. Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

3. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Abstract

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference4 articles.

1. Non-invasive monitoring for rejection in kidney transplant recipients after SARS-CoV-2 mRNA vaccination.;Al Jurdi;Front Immunol,2022

2. Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.;Al Jurdi;Kidney Int,2022

3. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.;Tan;Nat Biotechnol,2020

4. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.;Davis-Gardner;N Engl J Med,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients;Transplantation Direct;2023-09-20

2. Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease;Kidney International Reports;2023-07